January 15, 2022
2 min watch
Save
VIDEO: Chan shares ‘exciting’ updates to pediatric retina
You've successfully added to your alerts. You will receive an email when new content is published.
Click Here to Manage Email Alerts
Click Here to Manage Email Alerts
We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.
WAIKOLOA, Hawaii — R.V. Paul Chan, MD, the head of the department of ophthalmology at the University of Illinois College of Medicine, discussed updates on pediatric retina during a presentation at Hawaiian Eye 2022.
“We are in the era of anti-VEGF for pediatric retinal disease,” Chan said. “I think, over the past 10-15 years, we have been using it more often. But now, what’s exciting is, we have some clinical trial data ... showing that it is effective for the treatment of active ROP.”
Published by:
Sources/Disclosures
Collapse
Source:
R.V. Paul Chan, MD
Disclosures:
Chan reports no relevant financial disclosures.
Read more about
You've successfully added to your alerts. You will receive an email when new content is published.
Click Here to Manage Email Alerts
Click Here to Manage Email Alerts
We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.